![Quiver Logo](/static/img/logo-icon.png)
![CNSP logo](https://quiver-logos.s3.us-east-2.amazonaws.com/cnsp.png)
CNS Pharmaceuticals, Inc. Common Stock
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CNSP Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CNSP by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CNSP's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CNSP
Recent picks made for CNSP stock on CNBC
ETFs with the largest estimated holdings in CNSP
Flights by private jets registered to CNSP
![Quiver Logo](/static/img/logo-icon.png)